应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AVTE Aerovate Therapeutics, Inc.
盘后交易 07-16 18:42:26 EDT
1.99
+0.09
+4.74%
盘后
1.99
+0.00
0.00%
18:40 EDT
最高
2.00
最低
1.88
成交量
47.55万
今开
1.88
昨收
1.90
日振幅
6.32%
总市值
5,736万
流通市值
2,025万
总股本
2,882万
成交额
92.98万
换手率
4.67%
流通股本
1,017万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Aerovate Therapeutics, Inc.盘中异动 临近收盘急速上涨5.00%
自选股智能写手 · 04:00
Aerovate Therapeutics, Inc.盘中异动 临近收盘急速上涨5.00%
Aerovate Therapeutics, Inc.盘中异动 股价大跌5.46%报1.65美元
自选股智能写手 · 07-09
Aerovate Therapeutics, Inc.盘中异动 股价大跌5.46%报1.65美元
Aerovate Therapeutics, Inc.盘中异动 早盘股价大跌5.52%
自选股智能写手 · 06-26
Aerovate Therapeutics, Inc.盘中异动 早盘股价大跌5.52%
Aerovate Therapeutics, Inc.盘中异动 快速下跌5.71%
自选股智能写手 · 06-24
Aerovate Therapeutics, Inc.盘中异动 快速下跌5.71%
Aerovate Therapeutics, Inc.盘中异动 急速拉升10.27%
自选股智能写手 · 06-21
Aerovate Therapeutics, Inc.盘中异动 急速拉升10.27%
美国研究综述-Aerovate Therapeutics、波音、Wingstop
Reuters · 06-18
美国研究综述-Aerovate Therapeutics、波音、Wingstop
BUZZ-在竞争对手 Aerovate 取消先导药物后期试验后,Gossamer Bio 公司业绩上涨
Reuters · 06-17
BUZZ-在竞争对手 Aerovate 取消先导药物后期试验后,Gossamer Bio 公司业绩上涨
BUZZ-Aerovate公司取消肺部疾病药物试验,创历史新低
Reuters · 06-17
BUZZ-Aerovate公司取消肺部疾病药物试验,创历史新低
Aerovate Therapeutics, Inc.股价重挫90.41% 市值跌6149.51万美元
自选股智能写手 · 06-17
Aerovate Therapeutics, Inc.股价重挫90.41% 市值跌6149.51万美元
BUZZ-Aerovate公司取消肺部疾病药物后期试验后暴跌
Reuters · 06-17
BUZZ-Aerovate公司取消肺部疾病药物后期试验后暴跌
更新版 1-Aerovate放弃肺部疾病药物的后期研究
Reuters · 06-17
更新版 1-Aerovate放弃肺部疾病药物的后期研究
中期试验失败后,Aerovate 取消了高血压药物的后期研究
Reuters · 06-17
中期试验失败后,Aerovate 取消了高血压药物的后期研究
Aerovate Therapeutics, Inc.盘中异动 快速上涨5.13%
自选股智能写手 · 06-14
Aerovate Therapeutics, Inc.盘中异动 快速上涨5.13%
Aerovate Therapeutics, Inc.盘中异动 快速上涨7.19%报23.85美元
自选股智能写手 · 06-12
Aerovate Therapeutics, Inc.盘中异动 快速上涨7.19%报23.85美元
Aerovate Therapeutics, Inc.盘中异动 早盘急速上涨5.11%
自选股智能写手 · 06-10
Aerovate Therapeutics, Inc.盘中异动 早盘急速上涨5.11%
Aerovate Therapeutics, Inc.盘中异动 早盘大幅拉升5.14%
自选股智能写手 · 06-05
Aerovate Therapeutics, Inc.盘中异动 早盘大幅拉升5.14%
Aerovate Therapeutics, Inc.盘中异动 快速下挫5.12%
自选股智能写手 · 06-04
Aerovate Therapeutics, Inc.盘中异动 快速下挫5.12%
Aerovate Therapeutics, Inc.盘中异动 大幅下跌5.46%报18.71美元
自选股智能写手 · 05-22
Aerovate Therapeutics, Inc.盘中异动 大幅下跌5.46%报18.71美元
Aerovate Therapeutics, Inc.盘中异动 大幅拉升7.42%
自选股智能写手 · 05-14
Aerovate Therapeutics, Inc.盘中异动 大幅拉升7.42%
Aerovate Therapeutics, Inc.盘中异动 早盘股价大跌5.01%
自选股智能写手 · 05-10
Aerovate Therapeutics, Inc.盘中异动 早盘股价大跌5.01%
公司概况
公司名称:
Aerovate Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Aerovate Therapeutics, Inc.于2018年7月根据特拉华州法律注册成立。他们是一家临床阶段的生物制药公司,专注于开发可显著改善罕见心肺疾病患者生活的药物。他们最初的重点是推进AV-101,这是他们的伊马替尼干粉吸入制剂,用于治疗肺动脉高压或PAH,这是一种影响美国和欧洲约70,000人的毁灭性疾病。伊马替尼,作为格列卫片剂销售,最初是为治疗多种癌症而开发的。在诺华(Novartis)进行的一项国际3期试验中,口服伊马替尼在PAH患者的主要终点、六分钟步行距离和多个次要血流动力学终点方面也表现出统计学显著改善,但由于不良事件或AE导致耐受性差,并且从未获得批准用于治疗PAH。
发行价格:
--
{"stockData":{"symbol":"AVTE","market":"US","secType":"STK","nameCN":"Aerovate Therapeutics, Inc.","latestPrice":1.99,"timestamp":1721160000000,"preClose":1.9,"halted":0,"volume":475454,"hourTrading":{"tag":"盘后","latestPrice":1.99,"preClose":1.99,"latestTime":"18:40 EDT","volume":21435,"amount":42679.262795999995,"timestamp":1721169607661},"delay":0,"floatShares":10173759,"shares":28822334,"eps":-3.034284,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.09,"latestTime":"07-16 18:42:26 EDT","open":1.88,"high":2,"low":1.88,"amount":929770.1234317999,"amplitude":0.063158,"askPrice":1.99,"askSize":354,"bidPrice":1.93,"bidSize":310,"shortable":3,"etf":0,"ttmEps":-3.034284,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1721174400000},"adr":0,"listingDate":1625025600000,"adjPreClose":1.9,"preHourTrading":{"tag":"盘前","latestPrice":1.87,"preClose":1.9,"latestTime":"09:29 EDT","volume":1958,"amount":3625.7120108,"timestamp":1721136599910},"postHourTrading":{"tag":"盘后","latestPrice":1.99,"preClose":1.99,"latestTime":"18:40 EDT","volume":21435,"amount":42679.262795999995,"timestamp":1721169607661},"volumeRatio":0.865875,"impliedVol":1.8036,"impliedVolPercentile":0.5577},"requestUrl":"/m/hq/s/AVTE/wiki","defaultTab":"wiki","newsList":[{"id":"2452473119","title":"Aerovate Therapeutics, Inc.盘中异动 临近收盘急速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452473119","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452473119?lang=zh_cn&edition=full","pubTime":"2024-07-17 04:00","pubTimestamp":1721160027,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日04时00分,Aerovate Therapeutics, Inc.股票出现异动,股价急速上涨5.00%。Aerovate Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.31%。其相关个股中,Silo Pharma, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大,Silo Pharma, Inc.、Scisparc Ltd.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为4622.06%、1362.80%、440.35%,振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Silo Pharma, Inc.、Scisparc Ltd.,振幅分别为79.41%、75.69%、72.88%。Aerovate Therapeutics, Inc.公司简介:Aerovate Therapeutics Inc 是一家临床阶段生物制药公司,致力于开发改善罕见心肺疾病患者生活的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170400279681d46e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170400279681d46e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","AVTE","LENZ"],"gpt_icon":0},{"id":"2450502667","title":"Aerovate Therapeutics, Inc.盘中异动 股价大跌5.46%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450502667","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450502667?lang=zh_cn&edition=full","pubTime":"2024-07-09 22:32","pubTimestamp":1720535570,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日22时32分,Aerovate Therapeutics, Inc.股票出现波动,股价大幅下跌5.46%。截至发稿,该股报1.65美元/股,成交量11.1943万股,换手率0.39%,振幅5.46%。Aerovate Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.66%。Aerovate Therapeutics, Inc.公司简介:Aerovate Therapeutics Inc 是一家临床阶段生物制药公司,致力于开发改善罕见心肺疾病患者生活的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709223251941f573b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709223251941f573b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4139","AVTE"],"gpt_icon":0},{"id":"2446942293","title":"Aerovate Therapeutics, Inc.盘中异动 早盘股价大跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446942293","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446942293?lang=zh_cn&edition=full","pubTime":"2024-06-26 22:39","pubTimestamp":1719412790,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日22时39分,Aerovate Therapeutics, Inc.股票出现波动,股价快速下跌5.52%。Aerovate Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.87%。其相关个股中,Anew Medical, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大,Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃,换手率分别为487.79%、115.08%、92.33%,振幅较大的相关个股有Anew Medical, Inc.、Effector Therapeutics Inc C/Wts 31/12/2025 、Moolec Science Sa C/Wts ,振幅分别为107.88%、51.85%、39.62%。Aerovate Therapeutics, Inc.公司简介:Aerovate Therapeutics Inc 是一家临床阶段生物制药公司,致力于开发改善罕见心肺疾病患者生活的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626223950941f16c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626223950941f16c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","LENZ","AVTE"],"gpt_icon":0},{"id":"2445279072","title":"Aerovate Therapeutics, Inc.盘中异动 快速下跌5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445279072","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445279072?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:32","pubTimestamp":1719235952,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时32分,Aerovate Therapeutics, Inc.股票出现异动,股价快速下挫5.71%。Aerovate Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.68%。其相关个股中,Revelation Biosciences, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、阿里拉姆制药涨幅较大,Revelation Biosciences, Inc.、Gri Bio, Inc.、Effector Therapeutics, Inc.较为活跃,换手率分别为380.25%、43.83%、34.67%,振幅较大的相关个股有Revelation Biosciences, Inc.、Geovax Labs, Inc.、Seastar Medical Holding Corporation,振幅分别为26.54%、18.45%、12.07%。Aerovate Therapeutics, Inc.公司简介:Aerovate Therapeutics Inc 是一家临床阶段生物制药公司,致力于开发改善罕见心肺疾病患者生活的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624213233af8eeb6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624213233af8eeb6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","AVTE","LENZ"],"gpt_icon":0},{"id":"2445750287","title":"Aerovate Therapeutics, Inc.盘中异动 急速拉升10.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445750287","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445750287?lang=zh_cn&edition=full","pubTime":"2024-06-21 21:32","pubTimestamp":1718976721,"startTime":"0","endTime":"0","summary":"北京时间2024年06月21日21时32分,Aerovate Therapeutics, Inc.股票出现波动,股价快速拉升10.27%。Aerovate Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Ocean Biomedical Inc C/Wts 14/02/2028 、Sarepta Therapeutics, Inc.涨幅较大,Qualigen Therapeutics, Inc.、Kintara Therapeutics, Inc.、Cero Therapeutics Holdings, Inc.较为活跃,换手率分别为182.80%、30.39%、11.12%,振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Sab Biotherapeutics, Inc.、Cardio Diagnostics Holdings Inc.,振幅分别为31.14%、16.97%、10.66%。Aerovate Therapeutics, Inc.公司简介:Aerovate Therapeutics Inc 是一家临床阶段生物制药公司,致力于开发改善罕见心肺疾病患者生活的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062121320195c9a5c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062121320195c9a5c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","AVTE"],"gpt_icon":0},{"id":"2444917216","title":"美国研究综述-Aerovate Therapeutics、波音、Wingstop","url":"https://stock-news.laohu8.com/highlight/detail?id=2444917216","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444917216?lang=zh_cn&edition=full","pubTime":"2024-06-18 15:24","pubTimestamp":1718695494,"startTime":"0","endTime":"0","summary":" 路透6月18日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价,其中包括 Aerovate Therapeutics、波音和 Wingstop。* 波音公司 :加拿大皇家银行将目标价从215美元下调至210美元 * Mirum Pharmaceuticals Inc :Evercore ISI将目标价从53美元上调至62美元 * Transdigm Group Inc :加拿大皇家银行将目标价从1400美元上调至1500美元 * Wingstop Inc :Stifel将目标价从420美元上调至460美元 以下是路透周二报道的美国公司研究报告摘要。* Aerovate Therapeutics Inc :TD Cowen将其评级从 \"买入 \"下调至 \"持有\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","ARHS","BK4551","WING","LU2098885051.SGD","OVID","LU1435385759.SGD","LU1429558221.USD","PTLO","BK4550","BK4566","MIRM","BK4139","LU2065731478.USD","HUMA","BK4504","AVTE","RBA","BK4585","LENZ","BK4564","BK4232","BA","BK4177","LU0757428866.USD","LU1815336091.USD","ODFL","BK4516","BK4187","BYON","LU1303367103.USD","LU2326559502.SGD","BK4588","PRMW","BK4209","GRNT","BK4539","BK4178","TDG","BK4213","BK4137","BK4022","BK4563","LOAR","LU0198837287.USD"],"gpt_icon":1},{"id":"2444913611","title":"BUZZ-在竞争对手 Aerovate 取消先导药物后期试验后,Gossamer Bio 公司业绩上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2444913611","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444913611?lang=zh_cn&edition=full","pubTime":"2024-06-17 23:51","pubTimestamp":1718639505,"startTime":"0","endTime":"0","summary":" 6月17日 - ** 在竞争对手Aerovate Therapeutics 取消了 。** Aerovate的唯一产品AV-101在一项中后期研究的中期部分未能达到关键目标,导致股价下跌超过92%,至1.89美元。** AV-101 在患有肺动脉高压 的成人中进行了测试,其特点是肺部动脉血压过高。** Gossamer 公司的实验性疗法 seralutinib 目前正处于 PAH 治疗的后期开发阶段。** 券商 Leerink Partners 表示,Aerovate 的更新没有对已经取得令人鼓舞的中期结果的 GOSS 进行疗效解读。** 随着 AVTE 项目的终止,GOSS 可能会有更多的 PAH 患者可以入组。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","AVTE","BUZZ","BK4505","BK4139","GOSS"],"gpt_icon":0},{"id":"2444774198","title":"BUZZ-Aerovate公司取消肺部疾病药物试验,创历史新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2444774198","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444774198?lang=zh_cn&edition=full","pubTime":"2024-06-17 22:20","pubTimestamp":1718634035,"startTime":"0","endTime":"0","summary":" (更新) 6月17日 - ** Aerovate 股价下跌约91%,跌至2.25美元的历史新低** 在中期研究未能达到主要目标后,该公司表示将停止 ,并关闭其肺病药物的后期试验** 在一项中后期试验中,药物开发商正在研究 其主导药物 AV-101对患有肺动脉高压的成人患者的治疗效果 ** PAH 的特征是肺部动脉血压过高** 在中期研究中,与安慰剂相比,该药物没有达到改善从肺到心脏的血流量这一主要目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVTE","BUZZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2444878160","title":"Aerovate Therapeutics, Inc.股价重挫90.41% 市值跌6149.51万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444878160","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444878160?lang=zh_cn&edition=full","pubTime":"2024-06-17 21:31","pubTimestamp":1718631093,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日21时31分,Aerovate Therapeutics, Inc.股票出现波动,股价大幅跳水90.41%。Aerovate Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.20%。其相关个股中,Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Xtl生物制药涨幅较大,Scinai Immunotherapeutics Ltd、Mustang Bio, Inc.、Longeveron Inc.较为活跃,换手率分别为2114.38%、363.30%、58.17%,振幅较大的相关个股有Mustang Bio, Inc.、Sellas Life Sciences Group, Inc.、Gri Bio, Inc.,振幅分别为22.15%、13.33%、10.70%。Aerovate Therapeutics, Inc.公司简介:Aerovate Therapeutics Inc 是一家临床阶段生物制药公司,致力于开发改善罕见心肺疾病患者生活的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061721313395b9ddb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061721313395b9ddb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","AVTE","LENZ"],"gpt_icon":0},{"id":"2444616783","title":"BUZZ-Aerovate公司取消肺部疾病药物后期试验后暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2444616783","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444616783?lang=zh_cn&edition=full","pubTime":"2024-06-17 21:27","pubTimestamp":1718630843,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 6月17日 - ** Aerovate 股价盘前下跌约91%至2.26美元** 该公司表示,由于未能达到中期研究的主要目标,它将停止 (link),并关闭其肺病药物的后期试验。** 在一项中后期试验中,该药物开发商正在研究 (link) AV-101,一种伊马替尼的干粉吸入制剂,用于治疗成人肺动脉高压(PAH) ** PAH 的特征是肺部动脉血压过高** 在中期研究中,与安慰剂相比,该药没有达到改善从肺到心脏的血流量这一主要目标 ** 公司计划稍后公布中期试验的全部数据,具体时间待定。** 截至上次收盘,股价累计上涨约 9","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BUZZ","BK4139","AVTE"],"gpt_icon":0},{"id":"2444162985","title":"更新版 1-Aerovate放弃肺部疾病药物的后期研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2444162985","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444162985?lang=zh_cn&edition=full","pubTime":"2024-06-17 21:16","pubTimestamp":1718630165,"startTime":"0","endTime":"0","summary":" 路透6月17日 - Aerovate Therapeutics 周一表示,由于其实验性肺部疾病药物在中期试验中失败,该公司正在关闭测试该药物的后期研究,这使得该公司股价在盘前交易中下跌了91%。PAH 是由肺部动脉收缩引起的,会导致高血压和气短、胸痛和头晕等症状。Aerovate公司说,该药在研究的几个次要目标上也没有显示出任何有意义的改善。根据这些数据,Aerovate 公司表示将停止该药物的后期研究和长期扩展研究。Aerovate公司表示,中期研究的详细数据将在晚些时候公布。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","AVTE"],"gpt_icon":0},{"id":"2444164523","title":"中期试验失败后,Aerovate 取消了高血压药物的后期研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2444164523","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444164523?lang=zh_cn&edition=full","pubTime":"2024-06-17 20:51","pubTimestamp":1718628696,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透6月17日 - Aerovate Therapeutics公司 周一表示,在中期试验未能达到主要目标后,该公司正在关闭一项测试其实验性高血压药物的后期研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVTE"],"gpt_icon":0},{"id":"2443637808","title":"Aerovate Therapeutics, Inc.盘中异动 快速上涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443637808","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443637808?lang=zh_cn&edition=full","pubTime":"2024-06-14 02:34","pubTimestamp":1718303689,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日02时34分,Aerovate Therapeutics, Inc.股票出现波动,股价快速上涨5.13%。Aerovate Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.32%。其相关个股中,Longeveron Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、乌龙制药涨幅较大,Longeveron Inc.、Biorestorative Therapies, Inc.、Cero Therapeutics Holdings, Inc.较为活跃,换手率分别为2761.91%、1300.54%、152.05%,振幅较大的相关个股有Longeveron Inc.、Cero Therapeutics Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为102.21%、82.05%、74.62%。Aerovate Therapeutics, Inc.公司简介:Aerovate Therapeutics Inc 是一家临床阶段生物制药公司,致力于开发改善罕见心肺疾病患者生活的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061402344996814104&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061402344996814104&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4139","AVTE"],"gpt_icon":0},{"id":"2442552809","title":"Aerovate Therapeutics, Inc.盘中异动 快速上涨7.19%报23.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442552809","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442552809?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:32","pubTimestamp":1718199144,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时32分,Aerovate Therapeutics, Inc.股票出现异动,股价快速上涨7.19%。Aerovate Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.39%。其相关个股中,Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Avidity Biosciences, Inc.、Molecular Partners Ag涨幅较大,Tonix Pharmaceuticals Holding Corp.、Tracon Pharmaceuticals, Inc.、Jaguar Health, Inc.较为活跃,换手率分别为38.24%、19.34%、3.70%,振幅较大的相关个股有Passage Bio, Inc.、Xortx Therapeutics Inc.、Prokidney Corp.,振幅分别为21.10%、20.93%、9.01%。Aerovate Therapeutics, Inc.公司简介:Aerovate Therapeutics Inc 是一家临床阶段生物制药公司,致力于开发改善罕见心肺疾病患者生活的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406122132249f352b20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406122132249f352b20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","AVTE","BK4139","BK4539"],"gpt_icon":0},{"id":"2442840882","title":"Aerovate Therapeutics, Inc.盘中异动 早盘急速上涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442840882","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442840882?lang=zh_cn&edition=full","pubTime":"2024-06-10 22:19","pubTimestamp":1718029145,"startTime":"0","endTime":"0","summary":"北京时间2024年06月10日22时19分,Aerovate Therapeutics, Inc.股票出现波动,股价急速拉升5.11%。Aerovate Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.15%。其相关个股中,Surrozen Inc C/Wts 01/08/2031 、Dermata Therapeutics Inc C/Wts 、Renovaro Inc.涨幅较大,Cns Pharmaceuticals, Inc.、Hoth Therapeutics, Inc.、Calidi Biotherapeutics, Inc.较为活跃,换手率分别为46.39%、38.28%、37.07%,振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Seastar Medical Holding Corp C/Wts 28/10/2027 、Renovaro Inc.,振幅分别为141.13%、134.12%、77.52%。Aerovate Therapeutics, Inc.公司简介:Aerovate Therapeutics Inc 是一家临床阶段生物制药公司,致力于开发改善罕见心肺疾病患者生活的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610221906941ed6cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610221906941ed6cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","AVTE","BK4139"],"gpt_icon":0},{"id":"2441700542","title":"Aerovate Therapeutics, Inc.盘中异动 早盘大幅拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441700542","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441700542?lang=zh_cn&edition=full","pubTime":"2024-06-05 23:04","pubTimestamp":1717599858,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日23时04分,Aerovate Therapeutics, Inc.股票出现异动,股价快速拉升5.14%。Aerovate Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.26%。其相关个股中,Virios Therapeutics, Inc.、Kineta, Inc.、Vir Biotechnology, Inc.涨幅较大,Cns Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc、Virios Therapeutics, Inc.较为活跃,换手率分别为58.35%、49.72%、17.56%,振幅较大的相关个股有Kineta, Inc.、Virios Therapeutics, Inc.、Biocardia Inc C/Wts 06/08/2024,振幅分别为63.28%、60.84%、41.80%。Aerovate Therapeutics, Inc.公司简介:Aerovate Therapeutics Inc 是一家临床阶段生物制药公司,致力于开发改善罕见心肺疾病患者生活的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605230419af8c2bc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605230419af8c2bc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","AVTE"],"gpt_icon":0},{"id":"2440932231","title":"Aerovate Therapeutics, Inc.盘中异动 快速下挫5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440932231","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440932231?lang=zh_cn&edition=full","pubTime":"2024-06-04 22:35","pubTimestamp":1717511723,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日22时35分,Aerovate Therapeutics, Inc.股票出现异动,股价大幅下挫5.12%。Aerovate Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.56%。其相关个股中,Annexon, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Cingulate Inc C/Wts 10/12/2026 涨幅较大,Bio-Path Holdings, Inc.、Fresh2 Group Limited、Annexon, Inc.较为活跃,换手率分别为59.72%、38.84%、35.28%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Annexon, Inc.、Silo Pharma, Inc.,振幅分别为181.00%、35.37%、28.08%。Aerovate Therapeutics, Inc.公司简介:Aerovate Therapeutics Inc 是一家临床阶段生物制药公司,致力于开发改善罕见心肺疾病患者生活的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060422352396811e5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060422352396811e5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","AVTE","BK4139","LENZ"],"gpt_icon":0},{"id":"2437829783","title":"Aerovate Therapeutics, Inc.盘中异动 大幅下跌5.46%报18.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437829783","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437829783?lang=zh_cn&edition=full","pubTime":"2024-05-22 23:06","pubTimestamp":1716390405,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日23时06分,Aerovate Therapeutics, Inc.股票出现波动,股价快速下挫5.46%。Aerovate Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.37%。其相关个股中,Igm Biosciences, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Humacyte Inc C/Wts 27/08/2026 涨幅较大,Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Coeptis Therapeutics Holdings, Inc.较为活跃,换手率分别为286.10%、144.86%、38.93%,振幅较大的相关个股有Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Alpha Tau Medical Ltd C/Wts 、Oragenics Inc.,振幅分别为57.14%、48.75%、47.70%。Aerovate Therapeutics, Inc.公司简介:Aerovate Therapeutics Inc 是一家临床阶段生物制药公司,致力于开发改善罕见心肺疾病患者生活的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052223064587e8916f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052223064587e8916f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","AVTE","LENZ"],"gpt_icon":0},{"id":"2435519937","title":"Aerovate Therapeutics, Inc.盘中异动 大幅拉升7.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435519937","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435519937?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:42","pubTimestamp":1715694124,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时42分,Aerovate Therapeutics, Inc.股票出现异动,股价急速上涨7.42%。Aerovate Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.17%。其相关个股中,Tc Biopharm Plc C/Wts 10/02/2028 、Nutriband Inc C/Wts 、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大,Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、Scorpius Holdings, Inc.较为活跃,换手率分别为50.24%、9.97%、8.76%,振幅较大的相关个股有Transcode Therapeutics, Inc.、Imunon, Inc.、Absci Corporation,振幅分别为21.54%、17.57%、16.99%。Aerovate Therapeutics, Inc.公司简介:Aerovate Therapeutics Inc 是一家临床阶段生物制药公司,致力于开发改善罕见心肺疾病患者生活的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514214205861ed19d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514214205861ed19d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","AVTE","BK4539","BK4139"],"gpt_icon":0},{"id":"2434956857","title":"Aerovate Therapeutics, Inc.盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434956857","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434956857?lang=zh_cn&edition=full","pubTime":"2024-05-10 22:28","pubTimestamp":1715351317,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日22时28分,Aerovate Therapeutics, Inc.股票出现波动,股价快速跳水5.01%。Aerovate Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.45%。Aerovate Therapeutics, Inc.公司简介:Aerovate Therapeutics Inc 是一家临床阶段生物制药公司,致力于开发改善罕见心肺疾病患者生活的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102228377a594271&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102228377a594271&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4539","AVTE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aerovatetx.com","stockEarnings":[{"period":"1week","weight":0.092},{"period":"1month","weight":-0.9228},{"period":"3month","weight":-0.9196},{"period":"6month","weight":-0.9058},{"period":"1year","weight":-0.8959},{"period":"ytd","weight":-0.916}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0345},{"period":"3month","weight":0.1152},{"period":"6month","weight":0.189},{"period":"1year","weight":0.2498},{"period":"ytd","weight":0.1814}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aerovate Therapeutics, Inc.于2018年7月根据特拉华州法律注册成立。他们是一家临床阶段的生物制药公司,专注于开发可显著改善罕见心肺疾病患者生活的药物。他们最初的重点是推进AV-101,这是他们的伊马替尼干粉吸入制剂,用于治疗肺动脉高压或PAH,这是一种影响美国和欧洲约70,000人的毁灭性疾病。伊马替尼,作为格列卫片剂销售,最初是为治疗多种癌症而开发的。在诺华(Novartis)进行的一项国际3期试验中,口服伊马替尼在PAH患者的主要终点、六分钟步行距离和多个次要血流动力学终点方面也表现出统计学显著改善,但由于不良事件或AE导致耐受性差,并且从未获得批准用于治疗PAH。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.121433},{"month":2,"riseRate":0.666667,"avgChangeRate":0.03264},{"month":3,"riseRate":0.666667,"avgChangeRate":0.32545},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.196019},{"month":5,"riseRate":0,"avgChangeRate":-0.133359},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.187689},{"month":7,"riseRate":0.75,"avgChangeRate":0.037118},{"month":8,"riseRate":0.333333,"avgChangeRate":0.043933},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.027426},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.094038},{"month":11,"riseRate":0.333333,"avgChangeRate":0.102326},{"month":12,"riseRate":0.666667,"avgChangeRate":0.285214}],"exchange":"NASDAQ","name":"Aerovate Therapeutics, Inc.","nameEN":"Aerovate Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.0","shortVersion":"4.25.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aerovate Therapeutics, Inc.(AVTE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aerovate Therapeutics, Inc.(AVTE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aerovate Therapeutics, Inc.,AVTE,Aerovate Therapeutics, Inc.股票,Aerovate Therapeutics, Inc.股票老虎,Aerovate Therapeutics, Inc.股票老虎国际,Aerovate Therapeutics, Inc.行情,Aerovate Therapeutics, Inc.股票行情,Aerovate Therapeutics, Inc.股价,Aerovate Therapeutics, Inc.股市,Aerovate Therapeutics, Inc.股票价格,Aerovate Therapeutics, Inc.股票交易,Aerovate Therapeutics, Inc.股票购买,Aerovate Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aerovate Therapeutics, Inc.(AVTE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aerovate Therapeutics, Inc.(AVTE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}